The project ‘Proteomic profiling of serum and cerebrospinal fluid to identify candidate biomarkers of Spinal Cord Injury severity and prognosis’ (EPIC-XS-0000379), in collaboration with the Spanish National Cancer Research Centre (CNIO), has received green light from the European Proteomics Infrastructure Consortium providing access (EU EPIC-XS).
Comments